SOX Clinical Trials

3 actively recruiting trials

Also known as: oxaliplatin and Tegafur

Pipeline

Phase 2: 2

Top Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
Southwest Hospital, China1
Harbin Medical University1

Indications

Cancer3
Gastric Cancer, Gastroesophageal Junction Cancer1
Gastroesophageal Junction Adenocarcinoma1
Gastric Adenocarcinoma1
Gastric Cancer1

Other3 trials

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

Phase 2

A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.